Terms: = Endocrine gland cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Diagnosis
9 results:
1. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
Qiao Y; Zhao J; Wu J; Cao L; Song G; Mao J
Medicine (Baltimore); 2024 Apr; 103(15):e37770. PubMed ID: 38608089
[TBL] [Abstract] [Full Text] [Related]
2. miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing dnmt3a, TET1 and HBP1 in ovarian carcinoma.
Zhao H; Feng L; Cheng R; Wu M; Bai X; Fan L; Liu Y
Cell Signal; 2024 Jan; 113():110936. PubMed ID: 37925048
[TBL] [Abstract] [Full Text] [Related]
3.
Wang K; Gong D; Qiao X; Zheng J
Life Sci Alliance; 2023 Apr; 6(5):. PubMed ID: 37085288
[TBL] [Abstract] [Full Text] [Related]
4. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
5. miR-145 promotes miR-133b expression through c-myc and dnmt3a-mediated methylation in ovarian cancer cells.
Li J; Zhang S; Zou Y; Wu L; Pei M; Jiang Y
J Cell Physiol; 2020 May; 235(5):4291-4301. PubMed ID: 31612498
[TBL] [Abstract] [Full Text] [Related]
6. Intermediate-Risk Papillary Thyroid cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
Llamas-Olier AE; Cuéllar DI; Buitrago G
Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
[TBL] [Abstract] [Full Text] [Related]
7. [Noninvasive examinations for localization of insulinoma].
Zhang TP; Zhao YP; Cong L; Liao Q; Dai MH; Guo JC
Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(18):1365-7. PubMed ID: 20092767
[TBL] [Abstract] [Full Text] [Related]
8. Utility of cell blocks in the diagnosis of thyroid aspirates.
Sanchez N; Selvaggi SM
Diagn Cytopathol; 2006 Feb; 34(2):89-92. PubMed ID: 16514670
[TBL] [Abstract] [Full Text] [Related]
9. [Thyroid cancer: 20 years experience in a hospital].
Isaac G; Roubicek M
Medicina (B Aires); 1996; 56(2):143-9. PubMed ID: 8935566
[TBL] [Abstract] [Full Text] [Related]
